We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · October 26, 2021

Kidney Function After Empagliflozin in Heart Failure Patients With and Without Type 2 Diabetes



Additional Info

Kidney Function After Initiation and Discontinuation of Empagliflozin in Patients With Heart Failure With and Without Type 2 Diabetes: Insights From the EMPERIAL Trials
Circulation 2021 Oct 12;144(15)1265-1267, SD Anker, P Ponikowski, C Wanner, E Pfarr, S Hauske, B Peil, A Salsali, I Ritter, A Koitka-Weber, M Brueckmann, J Lindenfeld, WT Abraham

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading